TOMM34 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL8288590	0.76	1/20
SCHEMBL7003055	0.74	1/20
SCHEMBL7002920	0.70	1/20
SCHEMBL11324603	0.66	1/20
SCHEMBL26293177	0.64	1/20
SCHEMBL26294993	0.63	1/20
SCHEMBL7003174	0.62	1/20
SCHEMBL8277600	0.62	1/20
SCHEMBL13856578	0.62	1/20
SCHEMBL18180597	0.62	1/20
SCHEMBL13856429	0.61	1/20
SCHEMBL11332843	0.60	1/20
SCHEMBL17817446	0.60	1/20
SCHEMBL1895132	0.60	1/20
SCHEMBL13856422	0.60	1/20
SCHEMBL26293182	0.59	1/20
SCHEMBL26293211	0.58	1/20
SCHEMBL4091316	0.57	1/20
SCHEMBL20831148	0.57	1/20
SCHEMBL26293025	0.57	1/20

Clinical trials — most relevant to TOMM34 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Impact if Desflurane Preconditioning on the Content of the Phospho-GSK-3b in the Rat's Neurons in the Model of I/R	PHASE4	WITHDRAWN
Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy	PHASE3	RECRUITING
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)	PHASE2	COMPLETED
Biologic Correlative Taxotere/AC	PHASE2	COMPLETED
Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly	PHASE1	COMPLETED
S-Equol in Alzheimer's Disease (SEAD) Trial	PHASE1	COMPLETED
Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D)	EARLY_PHASE1	COMPLETED
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy	nan	COMPLETED
Mitigating Mitochondrial RNA Release During Aging to Control Inflammation and Senescence	nan	NOT_YET_RECRUITING
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide	nan	RECRUITING
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study)	nan	COMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients	nan	UNKNOWN
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise	nan	COMPLETED
sCD163 in ALS Patients	nan	COMPLETED
Tissue Sample Study for Mitochondrial Disorders	nan	ENROLLING_BY_INVITATION
Polycystic Ovary Syndrome in Type 1 Diabetes	nan	NOT_YET_RECRUITING
Transcranial Photobiomodulation for the Treatment of Pediatric Depression	nan	WITHDRAWN
A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular Powerhouse) Dysfunction	nan	COMPLETED
Exercise-mediated Rescue of Mitochondrial Dysfunctions Driving Insulin Resistance	nan	COMPLETED
Calf Muscle Strength in Mitochondrial Diseases	nan	COMPLETED
Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Mitochondrial DNA in Peripheral Blood Leukocytes	nan	NOT_YET_RECRUITING
GDF-15 as a Biomarker for Mitochondrial Disease	nan	COMPLETED
Effect of Branched Chain Amino Acids on Muscle	nan	COMPLETED
Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS	nan	RECRUITING
Identification of New Candidate Genes in Patients With Mitochondrial Disease by High Resolution Chromosome Analysis on DNA Chip	nan	COMPLETED
Exercise Training Effects on Muscle Function in Adults With Mitochondrial Myopathy	nan	RECRUITING
The Natural History of Mitochondrial Diseases	nan	RECRUITING
Clinical Study of Hydroxytyrosol (HT) in Mitochondrial Diseases	nan	COMPLETED
MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial Diseases	nan	RECRUITING
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants	nan	RECRUITING

Related proteins — ESM-2 sequence neighbours (a TOMM34 binder may also engage these)

Protein	Name	Similarity
Q3KRD5	—	1.000	Q3KRD5 →
A4K2V0	—	1.000	A4K2V0 →
Q9CYG7	—	1.000	Q9CYG7 →
Q5U2X2	—	0.990	Q5U2X2 →
F1RBN2	—	0.987	F1RBN2 →
Q5JNB5	—	0.986	Q5JNB5 →
Q27968	—	0.986	Q27968 →
Q91YW3	—	0.986	Q91YW3 →
Q80ZX8	—	0.986	Q80ZX8 →
Q5ZI13	—	0.986	Q5ZI13 →
Q07617	—	0.986	Q07617 →
Q13217	—	0.985	Q13217 →
Q9R0T3	—	0.985	Q9R0T3 →
P27124	—	0.985	P27124 →
Q68FQ7	—	0.985	Q68FQ7 →
Q9M2V1	—	0.984	Q9M2V1 →
Q20683	—	0.984	Q20683 →
P30416	—	0.984	P30416 →
Q9TRY0	—	0.983	Q9TRY0 →
Q5RF88	—	0.983	Q5RF88 →
A0A0P0VG31	—	0.983	A0A0P0VG31 →
Q5U2T9	—	0.982	Q5U2T9 →
Q91Z38	—	0.982	Q91Z38 →
Q64378	—	0.982	Q64378 →
Q8SYD0	—	0.982	Q8SYD0 →
A8XHX1	—	0.982	A8XHX1 →
Q7XJS0	—	0.982	Q7XJS0 →
Q3ZBR5	—	0.982	Q3ZBR5 →
Q6MG81	—	0.981	Q6MG81 →
Q94C95	—	0.981	Q94C95 →